Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11032 results:
[ Συντάκτης(Asc)] Τίτλος Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
K
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2014).  The role of statins in the treatment of type 2 diabetes mellitus: an update.. Curr Pharm Des. 20(22), 3665-74.
Katsiki, N., Hatzitolios A. I., & Mikhailidis D. P. (2011).  Naltrexone sustained-release (SR) + bupropion SR combination therapy for the treatment of obesity: 'a new kid on the block'?. Ann Med. 43(4), 249-58.
Katsiki, N., Athyros V. G., & Karagiannis A. (2016).  Exploring the Management of Statin Intolerant Patients: 2016 and Beyond.. Curr Vasc Pharmacol. 14(6), 523-533.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2011).  Ezetimibe and low density lipoprotein subfractions: an ongoing debate.. Curr Med Res Opin. 27(3), 693-5.
Katsiki, N., Athyros V. G., & Karagiannis A. (2014).  Beneficial effects of high atorvastatin dose reloading prior to percutaneous coronary intervention.. Curr Med Res Opin. 30(1), 55.
Katsiki, N., Athyros V. G., & Mikhailidis D. P. (2015).  Statin therapy and cardiovascular outcomes after coronary revascularization in the elderly.. Atherosclerosis. 238(2), 182-4.
Katsiki, N., & Hatzitolios A. I. (2010).  Insulin-sensitizing agents in the treatment of polycystic ovary syndrome: an update.. Curr Opin Obstet Gynecol. 22(6), 466-76.
Katsiki, N., Doumas M., Athyros V. G., & Karagiannis A. (2015).  Hyperuricemia as a risk factor for cardiovascular disease.. Expert Rev Cardiovasc Ther. 13(1), 19-20.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2011).  Hyperuricaemia and non-alcoholic fatty liver disease (NAFLD): a relationship with implications for vascular risk?. Curr Vasc Pharmacol. 9(6), 698-705.
Katsiki, N., Anagnostis P., Kotsa K., Goulis D. G., & Mikhailidis D. P. (2019).  Obesity, Metabolic Syndrome and the Risk of Microvascular Complications in Patients with Diabetes mellitus.. Curr Pharm Des. 25(18), 2051-2059.
Katsiki, N., Mikhailidis D. P., Athyros V. G., Hatzitolios A. I., Karagiannis A., & Banach M. (2010).  Are we getting to lipid targets in real life?. Arch Med Sci. 6(5), 639-41.
Katsiki, N., Athyros V. G., & Mikhailidis D. P. (2011).  The DEFINE study: a bright future for CETP inhibitors?. Expert Opin Investig Drugs. 20(3), 311-4.
Katsiki, N., Kollari E., Dardas S., Dardas P., Haidich A-B., Athyros V. G., et al. (2016).  Is There an Association Between Carotid-Femoral Pulse Wave Velocity and Coronary Heart Disease in Patients with Coronary Artery Disease: A Pilot Study.. Open Cardiovasc Med J. 10, 64-8.
Katsigiannopoulos, K., Georgiadou E., Pazarlis P., Karastergiou A., Papazisis G., Bozikas V., et al. (2010).  Psychotic disorder as a manifestation of Graves' disease.. Psychosomatics. 51(5), 449-50.
Katsiana, A., Strimpakos N., Ioannis V., Kapreli E., Sofologi M., Bonti E., et al. (2020).  Health-related Quality of Life in Children with Autism Spectrum Disorder and Children with Down Syndrome.. Mater Sociomed. 32(2), 93-98.
Katsi, V., Didagelos M., Skevofilax S., Armenis I., Kartalis A., Vlachopoulos C., et al. (2018).  Gut Microbiome - Gut Dysbiosis - Arterial Hypertension: New Horizons.. Curr Hypertens Rev.
Katsetos, C. D., Spandou E., Legido A., Taylor M. L., Zanelli S. A., de Chadarevian J-P., et al. (2001).  Acute Hypoxia-Induced Alterations of Calbindin-D 28k Immunoreactivity in Cerebellar purkinje Cells of the Guinea pig Fetus at Term. Journal of Neuropathology & Experimental Neurology. 6061156910385193135666548694628142(5), 470 - 482.
Katsarou, M-S., Papasavva M., Latsi R., Toliza I., Gkaros A-P., Papakonstantinou S., et al. (2018).  Correction to: Population-Based Analysis of Cluster Headache-Associated Genetic Polymorphisms.. J Mol Neurosci. 66(1), 155.
Katsarou, M-S., Papasavva M., Latsi R., Toliza I., Gkaros A-P., Papakonstantinou S., et al. (2018).  Population-Based Analysis of Cluster Headache-Associated Genetic Polymorphisms.. J Mol Neurosci. 65(3), 367-376.
Katsarou, Z., Bostantjopoulou S., Zikouli A., Kazazi E., Kafantari A., Tsipropoulou V., et al. (2010).  Performance of Greek demented and nondemented subjects on the Greek version of the Mattis Dementia Rating Scale. A validation study.. Int J Neurosci. 120(11), 724-30.
Katsarou, M-S., Sidiropoulou P., Ieronymaki D., Mastraftsi S., Sifaki M., Xenos K., et al. (2020).  Impact of vitamin D receptor gene polymorphisms on vitiligo susceptibility and clinical features in a Southeastern European Caucasian population.. Int J Mol Med. 46(5), 1899-1907.
Katsarolis, I., Poulakou G., Analitis A., Matthaiopoulou I., Roilides E., Antachopoulos C., et al. (2009).  Risk factors for nasopharyngeal carriage of drug-resistant Streptococcus pneumoniae: data from a nation-wide surveillance study in Greece.. BMC Infect Dis. 9, 120.
Katsaris, M. P., Adamis T., Pistiki A., Carrer D-P., Galani I., Sabracos L., et al. (2014).  Immunomodulatory intervention with interferon-γ in Escherichia coli pyelonephritis.. J Urol. 192(2), 600-6.
Katsaridis, S., Grammatikopoulou M. G., Gkiouras K., Tzimos C., Papageorgiou S. T., Markaki A. G., et al. (2020).  Low Reported Adherence to the 2019 American Diabetes Association Nutrition Recommendations among Patients with Type 2 Diabetes Mellitus, Indicating the Need for Improved Nutrition Education and Diet Care.. Nutrients. 12(11), 
Katsara, K., Psatha K., Kenanakis G., Aivaliotis M., & Papadakis V. M. (2022).  Subtyping on Live Lymphoma Cell Lines by Raman Spectroscopy. Materials. 15(2), 546.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές